Total IgE EQA
| Accreditation Status: | UKAS Schedule of Accreditation | ||||||||||
| Date Scheme started: | 1979 | ||||||||||
| Clinical Applicability: |
Diagnosis and management of allergic disease |
||||||||||
| Analytes: |
Total IgE (SER/031) |
||||||||||
| Units for Reporting: |
kU/L |
||||||||||
| Samples Distributed: | Liquid format. Normal and pathological human serum | ||||||||||
| Number of Distributions per year: | 6 | ||||||||||
| Number of Samples per Distribution: |
2 |
||||||||||
| Frequency of Distributions: | Every two months as outlined in the Distribution Schedule | ||||||||||
| Schedule of Analysis: | Data entry is via the web for the submission of results. Data analysis commences 21 days after sample dispatch. Late returns are accepted and will contribute to the laboratory's cumulative performance statistics. | ||||||||||
| Data Analysis: |
All Laboratory Trimmed Mean (ALTM) with truncation at 10th & 90th Percentiles and CV%. Reports show method specific statistics. Individual laboratory performance is expressed in terms of MRBIS, SDBIS, and MRVIS |
||||||||||
| Performance Scoring: | Chosen Coefficient of Variation for Total IgE is 8% MRVIS | ||||||||||
| Criteria of Performance: |
Laboratory performance is assessed over a running analytical window of 6 Distributions (12 months)
|
||||||||||
| Persistent Poor Performance: |
Defined as being in the Poor Performance category for two or more successive Distributions |
